Evotec SE (EVT.F)
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
3.45-0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-49.9%
The outlook
Evotec SE currently reads as leaning bearish based on buy — 2.4 avg of 7 analysts, below its 50- & 200-day averages, 5% of the way from its 52-week low to high, avg target +42% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 2.4 avg of 7 analysts
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Price targetAvg target +42% vs current price
Analyst price target
~12-month · 7 analysts4.90average target+41.9% vs now
Now 3.45
Low 3.50High 10.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$613.4M
52-wk high
7.49
52-wk low
3.24
50-day avg
4.56
200-day avg
5.23
Trailing P/E
—